Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.
$43.95 -0.53 (-1.19%)
As of 03/02/2021 15:59:57 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.